Editorial of special column on Drug targets and drug development for Alzheimer's disease
Wen-Xing Ding,
Russell H. Swerdlow
Affiliations
Wen-Xing Ding
Department of Pharmacology, Toxicology and Therapeutics, Department of Internal Medicine, the University of Kansas Medical Center, Kansas City, KS 66160, USA
Russell H. Swerdlow
Department of Neurology, the University of Kansas Medical Center, Kansas City, KS 66160, USA
